In a move aimed at widening access to artificial intelligence education, IIT Madras has launched Hindi versions of its popular AI for All courses on the SWAYAM Plus platform, allowing learners across ...

Parasakthi is visually rich and meticulously crafted. Despite its charged backdrop, the film falters narratively, weighed down by a sluggish love track and a bloated second half. The resulting is a ...

Erika Hamilton, MD, reports early trial data showing DB-1305/BNT325, a TROP2-targeted ADC, produced encouraging responses in heavily pretreated TNBC patients. DB-1305/BNT325, a TROP2-targeted antibody ...

Oct 20 (Reuters) - Iambic Therapeutics said on Monday early-stage data of its experimental drug showed anti-tumor activity in heavily pretreated cancer patients with mutations in the HER2 gene. The ...

The Trump administration announced late last month "bold actions to tackle the autism epidemic.” President Trump said there was a possible link between acetaminophen, the active ingredient in Tylenol, ...

A new review suggests CoQ10 could rejuvenate aging oocytes and enhance embryo quality, offering hope for women facing age-related fertility challenges while spotlighting the need for rigorous clinical ...

Japanese scientists have developed ADRIANA, a non-opioid painkiller that could provide powerful relief without the dangers of addiction. With successful trials already completed, large U.S. studies ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min A Tennessee-based company is ...

Eli Lilly, the maker of Zepbound and Mounjaro, said its experimental GLP-1 pill successfully helped adults with obesity lose weight in a Phase 3 trial, as the company moves closer to submitting the ...